FibroGen Current Ratio 2013-2019 | FGEN

FibroGen current ratio from 2013 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
FibroGen Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-09-30 $0.79B $0.09B 9.01
2019-06-30 $0.81B $0.08B 9.73
2019-03-31 $0.58B $0.09B 6.17
2018-12-31 $0.69B $0.09B 7.75
2018-09-30 $0.68B $0.10B 6.76
2018-06-30 $0.72B $0.09B 7.95
2018-03-31 $0.72B $0.08B 8.61
2017-12-31 $0.75B $0.09B 8.71
2017-09-30 $0.74B $0.07B 10.82
2017-06-30 $0.37B $0.06B 6.21
2017-03-31 $0.26B $0.06B 4.27
2016-12-31 $0.27B $0.07B 4.09
2016-09-30 $0.25B $0.06B 4.11
2016-06-30 $0.25B $0.07B 3.80
2016-03-31 $0.18B $0.06B 3.16
2015-12-31 $0.20B $0.07B 2.99
2015-09-30 $0.23B $0.06B 3.94
2015-06-30 $0.26B $0.06B 4.15
2015-03-31 $0.16B $0.05B 2.88
2014-12-31 $0.20B $0.06B 3.16
2014-09-30 $0.00B 0.00
2014-06-30 $0.00B 0.00
2014-03-31 $0.00B 0.00
2013-12-31 $0.14B $0.04B 3.83
2012-12-31 $0.05B $0.02B 2.23
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $3.747B $0.213B
FibroGen, Inc. is a research-based biotechnology company. It is focused on the discovery, development, and commercialization of therapeutic agents for treatment of anemia, fibrosis, cancer, and other serious unmet medical needs. The Company develops Roxadustat that is in Phase III clinical development for the treatment of anemia in chronic kidney disease; and FG-3019 which is in Phase II clinical development for the treatment of idiopathic pulmonary fibrosis, pancreatic cancer, and liver fibrosis. FibroGen, Inc. is headquartered in San Francisco, California.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $67.601B 40.44
Takeda Pharmaceutical (TAK) Japan $62.655B 9.90
Astellas Pharma (ALPMY) Japan $32.276B 16.12
Eisai (ESALY) Japan $21.537B 41.52
Merck (MKGAF) Germany $16.401B 22.38
Grifols, S.A (GRFS) Spain $16.027B 21.00
Neurocrine Biosciences (NBIX) United States $9.727B 459.22
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
Catalent (CTLT) United States $9.001B 36.62
Jazz Pharmaceuticals (JAZZ) Ireland $8.506B 10.86
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
Ionis Pharmaceuticals (IONS) United States $8.443B 17.10
IPSEN SA ADR (IPSEY) France $7.656B 0.00
STADA ARZNEIMI (STDAF) Germany $6.004B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.540B 0.00
Hypermarcas (HYPMY) Brazil $5.475B 16.65
Arrowhead Pharmaceuticals (ARWR) United States $4.555B 68.97
Evotec AG (EVTCY) Germany $4.229B 68.35
United Therapeutics (UTHR) United States $4.032B 0.00
Nektar Therapeutics (NKTR) United States $3.944B 0.00
Sage Therapeutics (SAGE) United States $3.797B 0.00
PTC Therapeutics (PTCT) United States $3.298B 0.00
Taro Pharmaceutical Industries (TARO) Israel $3.287B 12.10
ChemoCentryx (CCXI) United States $2.480B 0.00
Zogenix (ZGNX) United States $2.414B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.155B 0.00
Tilray (TLRY) Canada $2.120B 0.00
Xencor (XNCR) United States $2.106B 64.02
Heron Therapeutics (HRTX) United States $2.072B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.965B 62.65
Pacira Pharmaceuticals (PCRX) United States $1.832B 54.19
USANA Health Sciences (USNA) United States $1.741B 18.58
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.591B 10.86
CLINIGEN GP (CLIGF) United Kingdom $1.506B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.501B 0.00
Corcept Therapeutics (CORT) United States $1.461B 17.75
Endo (ENDP) Ireland $1.447B 2.66
Enanta Pharmaceuticals (ENTA) United States $1.148B 26.11
Karyopharm Therapeutics (KPTI) United States $1.101B 0.00
Portola Pharmaceuticals (PTLA) United States $1.092B 0.00
Aerie Pharmaceuticals (AERI) United States $1.045B 0.00
Dermira (DERM) United States $1.044B 0.00
Akebia Therapeutics (AKBA) United States $0.943B 0.00
Radius Health (RDUS) United States $0.900B 0.00
TherapeuticsMD (TXMD) United States $0.762B 0.00
Collegium Pharmaceutical (COLL) United States $0.723B 0.00
ImmunoGen (IMGN) United States $0.704B 0.00
Flexion Therapeutics (FLXN) United States $0.698B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.577B 0.00
Molecular Templates (MTEM) United States $0.534B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.502B 0.00
Translate Bio (TBIO) United States $0.484B 0.00
Ardelyx (ARDX) United States $0.472B 0.00
Organogenesis Holdings (ORGO) United States $0.468B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.462B 0.00
Innate Pharma SA (IPHYF) France $0.440B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.435B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.432B 18.61
Aptorum Group (APM) Hong Kong, SAR China $0.428B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.425B 51.50
Siga Technologies (SIGA) United States $0.413B 9.43
DURECT (DRRX) United States $0.406B 0.00
Calithera Biosciences (CALA) United States $0.388B 0.00
Lannett Co Inc (LCI) United States $0.383B 4.46
OptiNose (OPTN) United States $0.382B 0.00
Recro Pharma (REPH) United States $0.372B 0.00
Indivior (INVVY) United States $0.350B 1.26
Harpoon Therapeutics (HARP) United States $0.348B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.345B 0.00
Rafael Holdings (RFL) United States $0.325B 0.00
KalVista Pharmaceuticals (KALV) United States $0.322B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.309B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.285B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.254B 0.00
Concordia (CXRXF) Canada $0.248B 0.00
MEI Pharma (MEIP) United States $0.246B 0.00
Ocular Therapeutix (OCUL) United States $0.244B 0.00
Jounce Therapeutics (JNCE) United States $0.239B 3.20
Concert Pharmaceuticals (CNCE) United States $0.235B 0.00
IMV INC (IMV) Canada $0.212B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.209B 0.00
Nature's Sunshine Products (NATR) United States $0.190B 32.83
Taiwan Liposome (TLC) Taiwan $0.182B 0.00
Xeris Pharmaceuticals (XERS) United States $0.166B 0.00
CannTrust Holdings (CTST) Canada $0.166B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.153B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.144B 0.00
Redhill Biopharma (RDHL) Israel $0.132B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.131B 0.00
CV Sciences (CVSI) United States $0.116B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.114B 0.00
Otonomy (OTIC) United States $0.109B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
PolarityTE (PTE) United States $0.108B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.107B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.105B 0.00
Aquestive Therapeutics (AQST) United States $0.103B 0.00
Champions Oncology (CSBR) United States $0.097B 0.00
MediWound (MDWD) Israel $0.084B 0.00
Infinity Pharmaceuticals (INFI) United States $0.083B 0.00
Neos Therapeutics (NEOS) United States $0.080B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.078B 23.41
CTI BioPharma (CTIC) United States $0.078B 0.00
Aclaris Therapeutics (ACRS) United States $0.072B 0.00
Natural Alternatives (NAII) United States $0.069B 17.16
AgeX Therapeutics (AGE) United States $0.069B 0.00
Nivalis Therapeutics (ALPN) United States $0.067B 0.00
IsoRay (ISR) United States $0.067B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.065B 0.00
SCYNEXIS (SCYX) United States $0.061B 0.00
RENEURON GP (RNUGF) United Kingdom $0.061B 0.00
Onconova Therapeutics (ONTX) United States $0.057B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.052B 0.00
Jaguar Animal Health (JAGX) United States $0.049B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.048B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.048B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
Iterum Therapeutics (ITRM) Ireland $0.041B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.040B 0.00
Mannatechorporated (MTEX) United States $0.037B 0.00
PharmAthene (ALT) United States $0.031B 0.00
Biomerica (BMRA) United States $0.030B 0.00
Regulus Therapeutics (RGLS) United States $0.027B 0.00
India Globalization Capital (IGC) United States $0.027B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.027B 0.00
VAXART, INC (VXRT) United States $0.025B 0.00
China SXT Pharmaceuticals (SXTC) China $0.023B 0.00
Bio-Path Holdings (BPTH) United States $0.021B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Cardiome Pharma (CORV) Canada $0.021B 0.00
Novan (NOVN) United States $0.018B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Shineco (TYHT) China $0.017B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.016B 0.00
Cyanotech (CYAN) United States $0.015B 0.00
Lipocine (LPCN) United States $0.014B 0.00
Flex Pharma (SLRX) United States $0.014B 0.00
Heat Biologics (HTBX) United States $0.012B 0.00
Vical (BBI) United States $0.012B 0.00
HANCOCK JAFFE (HJLI) United States $0.011B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.010B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.009B 0.00
Hemispherx BioPharma (AIM) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Can-Fite Biopharma (CANF) Israel $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.003B 0.00